prostate cancer

Medifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ Device COLUMBIA, Md. and TORONTO, Dec.…

Medifocus, Inc. Submits For New Patent Titled “Thermodilatation and Thermocompression to Facilitate Targeted Cluster Tissue Ablation and Immune Response” COLUMBIA, MD and TORONTO, ON / ACCESSWIRE / November 29, 2018…